These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24610278)

  • 1. Treatment of hepatitis C after kidney transplant: a pooled analysis of observational studies.
    Fabrizi F; Penatti A; Messa P; Martin P
    J Med Virol; 2014 Jun; 86(6):933-40. PubMed ID: 24610278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients.
    Fabrizi F; Lunghi G; Dixit V; Martin P
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1413-22. PubMed ID: 17081162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral therapy of hepatitis C in chronic kidney diseases: meta-analysis of controlled clinical trials.
    Fabrizi F; Ganeshan SV; Lunghi G; Messa P; Martin P
    J Viral Hepat; 2008 Aug; 15(8):600-6. PubMed ID: 18444984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-based anti-viral therapy for hepatitis C virus infection after renal transplantation: an updated meta-analysis.
    Wei F; Liu J; Liu F; Hu H; Ren H; Hu P
    PLoS One; 2014; 9(4):e90611. PubMed ID: 24699257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon therapy of acute hepatitis C in dialysis patients: meta-analysis.
    Fabrizi F; Dixit V; Messa P; Martin P
    J Viral Hepat; 2012 Nov; 19(11):784-91. PubMed ID: 23043385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon monotherapy of chronic hepatitis C in dialysis patients: meta-analysis of clinical trials.
    Fabrizi F; Dixit V; Messa P; Martin P
    J Viral Hepat; 2008 Feb; 15(2):79-88. PubMed ID: 18184190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials.
    Fabrizi F; Dixit V; Martin P; Messa P
    J Viral Hepat; 2011 Jul; 18(7):e263-9. PubMed ID: 21108701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pegylated interferon monotherapy of chronic hepatitis C in dialysis patients: Meta-analysis of clinical trials.
    Fabrizi F; Dixit V; Messa P; Martin P
    J Med Virol; 2010 May; 82(5):768-75. PubMed ID: 20336712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral therapy (pegylated interferon and ribavirin) of hepatitis C in dialysis patients: meta-analysis of clinical studies.
    Fabrizi F; Dixit V; Messa P; Martin P
    J Viral Hepat; 2014 Oct; 21(10):681-9. PubMed ID: 25040244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C.
    Fernández I; Muñoz-Gómez R; Pascasio JM; Baliellas C; Polanco N; Esforzado N; Arias A; Prieto M; Castells L; Cuervas-Mons V; Hernández O; Crespo J; Calleja JL; Forns X; Londoño MC
    J Hepatol; 2017 Apr; 66(4):718-723. PubMed ID: 28039098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients.
    Fabrizi F; Dulai G; Dixit V; Bunnapradist S; Martin P
    Aliment Pharmacol Ther; 2003 Dec; 18(11-12):1071-81. PubMed ID: 14653826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral therapy of symptomatic HCV-associated mixed cryoglobulinemia: meta-analysis of clinical studies.
    Fabrizi F; Dixit V; Messa P
    J Med Virol; 2013 Jun; 85(6):1019-27. PubMed ID: 23588727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comment on Fabrizi et al.: Treatment of hepatitis C after kidney transplant: A pooled analysis of observational studies.
    Pan YN; Luo YJ; He S
    J Med Virol; 2015 Aug; 87(8):1255. PubMed ID: 26037651
    [No Abstract]   [Full Text] [Related]  

  • 15. Pegylated Interferon Mono-Therapy of Chronic Hepatitis C in the Dialysis Population: Systematic Review and Meta-Analysis.
    Fabrizi F; Dixit V; Messa P; Martin P
    Ther Apher Dial; 2015 Dec; 19(6):611-21. PubMed ID: 26197927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reply to the letter by Pan Yanna et al. 'treatment of hepatitis C after kidney transplant: A pooled analysis of observational studies'.
    Fabrizi F; Messa P; Martin P
    J Med Virol; 2015 Aug; 87(8):1256-7. PubMed ID: 26037652
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of low accelerating dose regimen of interferon/ribavirin antiviral therapy in patients with hepatitis C virus recurrence after liver transplantation.
    Su H; Liu Z; Sun Y; Li H; Zhou S; Zhou X; Gao Y; Tang R; Zhang D; Zhang M
    Ann Transplant; 2015 May; 20():263-8. PubMed ID: 25975740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis: anti-viral therapy of hepatitis B virus-associated glomerulonephritis.
    Fabrizi F; Dixit V; Martin P
    Aliment Pharmacol Ther; 2006 Sep; 24(5):781-8. PubMed ID: 16918881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Panel reactive antibodies in predicting hepatitis C virus treatment outcome in kidney transplant candidates.
    Öcal S; Harmancı Ö; Korkmaz M; Ensaroğlu F; Çolak T; Selçuk H; Moray G; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():193-6. PubMed ID: 25894153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C treatment in patients with kidney disease.
    Fabrizi F; Aghemo A; Messa P
    Kidney Int; 2013 Nov; 84(5):874-9. PubMed ID: 23823603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.